Previous research has demonstrated that the exogenous administration of AI-2 contributes to a reduction in intestinal TNF-α and an increase in IL-10, resulting in the attenuation of the inflammatory responses in mice with necrotizing enterocolitis (NEC) [20]. This evidence concerns the gene IL10 and necrotizing enterocolitis.